Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results

Por Vitone, Francesca, Gibellini, Davide, Schiavone, Pasqua, D'Antuono, Antonietta, Gianni, Lorenzo, Bon, Isabella, Re, Maria Carla
Publicado em 2006

Lipoplatin Treatment in Lung and Breast Cancer

Por Fantini, Manuela, Gianni, Lorenzo, Santelmo, Carlotta, Drudi, Fabrizio, Castellani, Cinzia, Affatato, Alessandra, Nicolini, Mario, Ravaioli, Alberto
Publicado em 2011

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Publicado em 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

Por Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Publicado em 2006

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Por Colleoni, Marco, Sun, Zhuoxin, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Publicado no J Clin Oncol (2016)

Second non-breast primary cancer following adjuvant therapy for early breast cancer: A report from the International Breast Cancer Study Group

Por Gianni, Lorenzo, Gelber, Shari, Ravaioli, Alberto, Price, Karen N., Panzini, Ilaria, Fantini, Manuela, Castiglione-Gertsch, Monica, Pagani, Olivia, Simoncini, Edda, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Publicado em 2008

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

Por Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Publicado no Breast Cancer Res Treat (2016)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

Por Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Publicado em 2013

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Por Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Publicado no J Clin Oncol (2016)